Colorectal Cancer: CC-3 Antibody Study

We are testing a new bispecific antibody for patients with colorectal cancer to see if it is safe and effective. This is the first time this treatment is being evaluated in humans.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitaetsklinikum Frankfurt AöR
Medizinische Klinik 1
Frankfurt am Main, Germany
Medical Center - University Of Freiburg
Gastroinestinale Onkologie
Freiburg, Germany
Charite Universitaetsmedizin Berlin KöR
Klinik für Hämato-Onkologie
Teltow, Germany

Sponsor: Deutsches Krebsforschungszentrum (DKFZ)
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.